Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse

Muscle and Nerve

Volumn 19, Issue 12, 1996, Pages 1576-1585

  Anderson, Judy E ^a   Mcintosh, Laura M ^b   Poettcker, Robert ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE

Author keywords

deflazacort; diaphragm; Duchenne muscular dystrophy; glucocorticoid; mdx mouse; skeletal muscle regeneration

Indexed keywords

DEFLAZACORT; GLUCOCORTICOID; PREDNISONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; MOUSE; MUSCLE GROWTH; MUSCLE REGENERATION; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; DIAPHRAGM; LEG; MICE; MICE, INBRED MDX; MUSCLE FIBERS; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; MYOSITIS; PREDNISONE; PREGNENEDIONES; REGENERATION; WOUNDS, NONPENETRATING;

EID: 0029829392     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199612)19:12<1576::AID-MUS7>3.0.CO;2-7     Document Type: Article

References (52)

1. Allen RE, Rankin LL, Greene EA, Boxhorn LK, Johnson SE, Taylor RG, Pierce PR: Desmin is present in proliferating rat muscle satellite cells but not in bovine muscle satellite cells. J Cell Physiol 1991;149:525-535.
2. Anderson JE, Ovalle WK, Bressler BH: Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec 1987;219:243-257.
3. Anderson JE, Bressler BH, Ovalle WK: Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil 1988;9:499-515.
4. Anderson JE, Liu L, Kardami E: The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle. Muscle Nerve 1994;17:64-73.
5. Anderson JE, Mitchell CM, McGeachie JK, Grounds MD: The time course of basic fibroblast growth factor expression in crush-injured skeletal muscle of SJL/J and BALB/c mice. Exp Cell Res 1995;216:325-334.
6. Angelini C, Pegoraro E, Turella E, Intino MT, Pini A, Costa C: Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle Nerve 1994;17:386-391.
7. Angelini C, Pegoraro E, Perini F, Turella E, Intino M, Pini A, Ottolini A, Costa C: A trial with a new steroid in Duchenne muscular dystrophy, in Angelini C et al (eds): Muscular Dystrophy Research. New York, Elsevier, 1991, pp 173-179.
8. Bornemann A, Schmalbruch H: Desmin and vimentin in regenerating muscles. Muscle Nerve 1992;15:14-20.
9. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley RT, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L., King W, Robison J, Head RA, Province MA, Seyfried W, Mandel S: Clinical investigation of Duchenne dystrophy: interesting results in a trial of prednisone. Arch Neurol 1987;44: 812-817.
10. Carnac G, Albagli-Curiel O, Vandromme M, Pinset C, Montarras D, Laudet V, Bonnieu A: 3,5,3′-Triiodothyronine positively regulates both MyoD1 gene transcription and terminal differentiation in C2 myoblasts. Mol Endocrinol 1992;6: 1185-1194.
11. Coulton GR, Curtin NA, Morgan JE, Partridge TA: The mdx mouse skeletal muscle myopathy. II. Contractile properties. Neuropathol Appl Neurobiol 1988;14:299-314.
12. Cronstein BN, Kimmel SC, Levin RI, Martinuik F, Weissman G: A mechanism for the anti-inflammatory effects of cortico- steroids: the glucocorticoid receptor regulates leucocyte adhesion to endothelial cells and expression of endothelial- leucocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992;89:9991-9995.
13. Dangain J, Vrbova G: Muscle development in mdx mutant mice. Muscle Nerve 1984;7:700-704.
14. Dekhuijzen PNR, Gayan-Ramirez G, Bisschop A, de Bock V, Dom R, Bouillon R, Decramer M: Rat diaphragm contractility and histopathology are affected differently by low dose treatment with methylprednisolone and deflazacort. Eur Respir J 1995;8:824-830.
15. DeSilva S, Drachman DB: Prednisone treatment in Duchenne muscular dystrophy. Long term benefit. Arch Neurol 1987;44: 818-822.
16. Dubois C, Figarella-Branger D, Pastoret C, Rampini C, Karpati G, Rougon G: Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis. Neuromusc Disord 1994;4:171-182.
17. Dupont-Versteegden EE, McCarter RJ: Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 1992;15:1105-1110.
18. Fenichel GM, Florence MS, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W, Signore L, Pandya S, Schierbecker J, Wilson B: Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 1991;41:1874-1877.
19. Garrett KL, Anderson JE: Colocalization of bFGF and the myogenic regulatory gene myogenin in dystrophic mdx muscle precursors and young myotubes in vivo. Dev Biol 1995; 169:596-608.
20. Grounds MD, McGeachie JK: Myogenic cells of regenerating adult chicken muscle can fuse into myotubes after a single cell division in vivo. Exp Cell Res 1989;180:429-439.
21. Grounds MD, Garrett KL, Lai MC, Wright WE, Beilharz MW: Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Rees 1992;267: 99-104.
22. Guerriero V Jr, Florini JR: Dexamethasone effects on myoblast proliferation and differentiation. Endocrinology 1980;106: 1198-1202.
23. Hardiman O, Brown RH Jr, Beggs AH, Specht L, Sklar RM: Differential glucocorticoid effects on the fusion of Duchenne/Becker and control muscle cultures: pharmacological detection of accelerated aging in dystrophic muscle. Neurology 1992;42:1085-1091.
24. Hudecki MS, Pollina CM, Granchelli JA, Daly MK, Byrnes T, Wang JC, Hsiao JC: Strength and endurance in the therapeutic evaluation of prednisolone-treated mdx mice. Res Commun Chem Pathol Pharmacol 1993;79:45-60.
25. Irintchev A, Zeschnigk M, Starzinski-Powitz A, Wernig A: Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dm Dyn 1994;199:326-337.
26. Karpati G, Carpenter S: Small-caliber muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 1988; 11:795-803.
27. Khan MA: Corticosteroid therapy in Duchenne muscular dystrophy. J Neurol Sci 1993;120:8-14.
28. Kissel JT, Lynn DJ, Rammohan KW, Klein JP, Griggs RC, Moxley RT, Cwik VA, Brooke MH, Mendell JR: Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine- treated Duchenne muscular dystrophy. Neurology 1993;43: 532-536.
29. Krahn MJ, Anderson JE: Anabolic steroid treatment increases myofiber damage in mdx mouse muscular dystrophy. J Neurol Sci 1994;125:138-146.
30. Matsumura K, Campbell KP: Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nave 1994;17:2-15.
31. McGeachie JK, Grounds MD: Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice: an autoradiographic study. Cell Tissue Res 1987;248:125-130.
32. McIntosh LM, Pernitsky AN, Anderson JE: The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse. Muscle Nerve 1994;17:444-453.
33. McIntosh LM, Anderson JE: Hypothyroidism prolongs and increases mdx muscle precursor proliferation and delays monotube formation in normal and dystrophic limb muscle. Biochem Cell Biol 1995;73:181-190.
34. McIntosh L, Granberg K-E, Brière KM, Anderson JE: A nuclear magnetic resonance spectroscopy study of muscle growth and mdx dystrophy: correlation with histopathology. NMR in Biomed (submitted).
35. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA: MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996;10:1173-1183.
36. Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, Schierbecker J, Robison J, Kaiser K, Mandel S, Arfken C, Gilder B: Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320: 1592-1597.
37. Mesa LE, Dubrovsky AL, Corderi J, Marco P, Flores D: Steroids in Duchenne muscular dystrophy - deflazacort trial. Neuromusc Disord 1991;1:261-266.
38. Metzinger L, Passaquin A-C, Warter J-M, Poindron P: α-methylprednisolone promoted skeletal myogenesis in dystrophin- deficient and control mouse cultures. Neurosci Lett 1993;155: 171-174.
39. Metzinger L, Passaquin A-C, Vernier A, Thiriet N, Warter J-M, Poindron P: Lazaroids enhance skeletal myogenesis in primary cultures of dystrophin-deficient mdx mice. J Neurol Sci 1994;126:138-145.
40. Muscat GEO, Mynett-Johnson L, Dowhan D, Downes M, Griggs R: Activation of myoD gene transcription by 3,5,3′- triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors. Nucl Acids Res 1994;22:583-591.
41. Muscat GEO, Rea S, Downes M: Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis. Nucl Acids Res 1995;23:1311-1318.
42. O'Connell SL, Tresham J, Fortune CL, Farrugia W, McDougall JG, Scoggins BA, Wark JD: Effects of prednisolone and deflazacort on osteocalcin metabolism in sheep. Calcif Tissue Int 1993;53:117-121.
43. Ontell M, Feng KC, Klueber K, Dunn RF, Taylor F: Myosatellite cells, growth, and regeneration in murine dystrophic muscle: a quantitative study. Anat Rec 1984;208:159-174.
44. Passaquin AC, Metzinger L, Léger JJ, Warter J-M, Poindron P: Prednisolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell clusters from mdx mouse. J Neurosci Res 1993;35:363-372.
45. Pernitsky AN, McIntosh LM, Anderson JE: Hyperthyroidism impairs early repair in normal but not dystrophic mdx mouse tibialis anterior muscle. An in vivo study. Biochem Cell Biol 74:315-324.
46. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90: 3710-3714.
47. Rifai Z, Welle S, Moxley TR, Lorenson M, Griggs RC: Effect of prednisone on protein metabolism in Duchenne dystrophy. Am J Physiol (Endocrinol Metab 31): 1995;268:E67-E74.
48. Roberts R, Sobel BE: Elevated plasma MB creatine phospho- kinase activity. A specific marker for myocardial infarction in perioperative patients. Arch Intern Med 1976;136:421-424.
49. Sharma KR, Mynhier MA, Miller RG: Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology 1993;44:527-532.
50. Sklar RM, Brown RH Jr: Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vivo. J Neurol Sci 1991;101:73-81.
51. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991;352:536-538.
52. Weller B, Massa R, Karpati G, Carpenter S: Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles. Muscle Nerve 1991;14:771-774.